NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

With a viral vector, there is essentially a viral particle, which is programmed not ... killing them before the virus spreads. “With the initial single dose of Convidecia, we have over 90% ...

The vaccine is designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above. It will be used to support preventive vaccination in countries most ...